As Nrf2 is inhibited in several neurodegenerative diseases[1, 11], including AD[11] and ALS[12], as well as in APP/PS1 mutant mouse models of AD[13], deficits in this important cellular protection pathway may, in part, explain the cellular damage associated with these conditions. This evidence concerns the gene APP and Alzheimer disease.